OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
March 03, 2023
Lipids aren’t the only important ingredients influencing stability and in vivo performance.
Advancements in therapeutic modalities are necessitating change in drug delivery to help negate some of the expense of development and manufacturing.
EnteroBiotix is harnessing the power of the microbiome to target an array of diseases.
PAT is crucial to process control and real-time release in continuous manufacturing of solid-dosage drugs.
March 02, 2023
Shifts in pharmaceutical packaging have spurred tremendous growth in the pre-filled syringe fill/finish industry.
Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.
Stockpiling excess inventory is no longer enough to respond to supply chain volatility.
Technological advances will help ease pressure on pharma supply chains, allowing for greater visibility and less uncertainty.
The trends shaping the growth of the biologics outsourcing industry demand attention.
Lilly will cap insulin prices for patients with and without insurance at $35 per month.